Journey of the RA & Rheumatology Patient during COVID-19

Presented on March 26, 2020 by Dr. Janet Pope

During this 1-hour webinar, Dr. Pope will provide a comprehensive overview of how COVID-19 will affect RA/Rheumatology patients and their treatments.

Learning Objectives
At the end of this session, participants will be able to:

  1. discuss with their patients the use of DMARDs, biologics, NSAIDs, and steroids during the COVID-19 pandemic
  2. provide their patients with a course of action if they become infected
  3. evaluate the use of hydroxychloroquine (HCQ) with rheumatology patients
  4. evaluate the use of ibuprofen in infected patients

CanMEDS Roles

  1. Medical Expert
  2. Collaborator
  3. Scholar

This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.